H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $7.00 price target on BioStem Tech (NASDAQ: BSEM).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments